About

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Medical Information aims to empower the healthcare community to make informed decisions about our medicines, enabling better outcomes for patients.
NOUK2000233-01

Address

BMS House
Uxbridge Business Park
Sanderson Road
Uxbridge
Middlesex
UB8 1DH

Contact details

Medical Information phone number
+44-(0)800-7311 736

Hours of operation
Available 24 hours a day, 365 days a year

Medical Information email
medical.information@bms.com

Click to chat
https://www.bmsmedinfo.co.uk

Adverse events and product complaints

Please use the contact details below to provide adverse events or product complaints

Adverse event phone number
+4-(0)800-7311 736

Adverse event email
medical.information@bms.com

Submit medical inquiry URL
https://www.bmsmedinfo.co.uk/emirf_uk

Company website
https://www.bms.com/gb

Twitter
https://twitter.com/BMSNEWS

Facebook
https://www.facebook.com/BristolMyersSquibb

LinkedIn
https://www.linkedin.com/company/bristol-myers-squibb/

YouTube
https://www.youtube.com/bristolmyerssquibb

BMS products

Medicinal products marked withare subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

ADCORTYL®
(triamcinolone acetonide)

AZACTAM®
(aztreonam)

BARACLUDE®
(entecavir monohydrate)

ELIQUIS®
(apixiban)

EMPLICITI®
(elotuzumab)

ETOPOPHOS®
(etoposide phosphate)

EVOTAZ®
(atazanavir sulphate, cobicistat)

FUNGIZONE®
(amphotericin)

HYDREA®
(hydroxycarbamide)

KENALOG®
(triamcinolone acetonide)

NULOJIX®
(belatacept)

OPDIVO® + YERVOY® Regimen
(nivolumab, ipilimumab)

OPDIVO®
(nivolumab)

ORENCIA®
(abatacept)

PERFALGAN®
(paracetamol)

QUESTRAN®
(cholestyramine)

REYATAZ®
(atazanavir)

SPRYCEL®
(dasatinib)

SUSTIVA®
(efavirenz)

VEPESID®
(etoposide)

VIDEX®
(didanosine)

YERVOY®
(ipilimumab)

ZERIT®
(stavudine)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Last updated: 11/03/2020